MicroRNA-133b Inhibits Cell Proliferation and Invasion in Osteosarcoma by Targeting Sirt1

被引:25
作者
Shi Ying [1 ]
Huang Jianjun [2 ]
Yi Xue [1 ]
Yu Shuwei [1 ]
Zhang Liyuan [1 ]
Wang Jie [1 ]
Cheng Lixian [1 ]
机构
[1] Xiamen Med Coll, Dept Pathol, 1999 Guankou Rd, Xiamen 361023, Fujian, Peoples R China
[2] Xiamen HaiCang Hosp, Dept Orthoped, Xiamen, Fujian, Peoples R China
关键词
miR-133b; Sirt1; Osteosarcoma; Proliferation; Invasion; CANCER; PATHWAY;
D O I
10.3727/096504016X14826089198805
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs are a class of small noncoding RNAs that function as critical gene regulators through targeting mRNAs for translational repression or degradation. In this study, we showed that the miR-133b expression level was decreased while the Sirt1 mRNA expression level was increased in osteosarcoma tissue and cell lines. A low expression of miR-133b was significantly associated with tumor size, distant metastasis, and advanced clinical stage. In addition, osteosarcoma patients with a low miR-133b expression showed a worse prognosis when compared to those with a high level of miR-133b expression. Thus, we identified Sirt1 as a novel direct target of miR-133b. Overexpression of miR-133b suppressed Sirt1 expression and attenuated cell proliferation and invasion. Forced expression of Sirt1 could partly rescue the inhibitory effect of miR-133b in osteosarcoma cells. Our finding also suggested that the inhibitory effects of the miR-133b/ Sirt1 axis on osteosarcoma progression were involved in the Wnt/beta-catenin pathway. Taken together, these findings will shed light on the role and mechanism of miR-133b in regulating osteosarcoma cell growth via the miR-133b/ Sirt1 axis, and miR-133b may serve as a potential therapeutic target in osteosarcoma in the future.
引用
收藏
页码:1421 / 1430
页数:10
相关论文
共 21 条
  • [1] [Anonymous], PLOS ONE
  • [2] Osteosarcoma: The same old drugs or more?
    Bielack, Stefan S.
    Marina, Neyssa
    Ferrari, Stefano
    Helman, Lee J.
    Smeland, Sigbjorn
    Whelan, Jeremy S.
    Reaman, Gregory H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (18) : 3102 - 3103
  • [3] Wnt Pathway in Osteosarcoma, from Oncogenic to Therapeutic
    Cai, Yu
    Cai, Tiange
    Chen, Yan
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2014, 115 (04) : 625 - 631
  • [4] MicroRNA signatures in human cancers
    Calin, George A.
    Croce, Carlo M.
    [J]. NATURE REVIEWS CANCER, 2006, 6 (11) : 857 - 866
  • [5] MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells
    Chan, JA
    Krichevsky, AM
    Kosik, KS
    [J]. CANCER RESEARCH, 2005, 65 (14) : 6029 - 6033
  • [6] MicroRNAs and the hallmarks of cancer
    Dalmay, T.
    Edwards, D. R.
    [J]. ONCOGENE, 2006, 25 (46) : 6170 - 6175
  • [7] MicroRNA-199a-3p Is Downregulated in Human Osteosarcoma and Regulates Cell Proliferation and Migration
    Duan, Zhenfeng
    Choy, Edwin
    Harmon, David
    Liu, Xianzhe
    Susa, Michiro
    Mankin, Henry
    Hornicek, Francis
    [J]. MOLECULAR CANCER THERAPEUTICS, 2011, 10 (08) : 1337 - 1345
  • [8] MiR-199a-3p Regulates mTOR and c-Met to Influence the Doxorubicin Sensitivity of Human Hepatocarcinoma Cells
    Fornari, Francesca
    Milazzo, Maddalena
    Chieco, Pasquale
    Negrini, Massimo
    Calin, George Adrian
    Grazi, Gian Luca
    Pollutri, Daniela
    Croce, Carlo Maria
    Bolondi, Luigi
    Gramantieri, Laura
    [J]. CANCER RESEARCH, 2010, 70 (12) : 5184 - 5193
  • [9] MicroRNAs in cell proliferation, cell death, and tumorigenesis
    Hwang, HW
    Mendell, JT
    [J]. BRITISH JOURNAL OF CANCER, 2006, 94 (06) : 776 - 780
  • [10] Atomic force microscopy on chromosomes, chromatin and DNA: A review
    Kalle, Wouter
    Strappe, Padraig
    [J]. MICRON, 2012, 43 (12) : 1224 - 1231